Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Muhammad Jami Husain

Showing results (21-30 of 40) with videos related to

Pageof 4
Sort By:
PLOS Global Public Health|February 12, 2024
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countriesChaoyang Li, Garrison Spencer, Muhammad Jami Husain, et al.
MMWR. Morbidity and Mortality Weekly Report|May 29, 2015
Approaches for controlling illicit tobacco trade--nine countries and the European UnionHana Ross, Muhammad Jami Husain, Deliana Kostova, et al.
Seminars in Arthritis and Rheumatism|April 13, 2012
No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine dataSinead Brophy, Roxanne Cooksey, Mark Atkinson, et al.
BMJ Open|April 16, 2024
Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-pointsBrian Hutchinson, Adam Walter, Norm Campbell, et al.
BMJ Global Health|September 11, 2020
The cost-effectiveness of hypertension management in low-income and middle-income countries: a reviewDeliana Kostova, Garrison Spencer, Andrew E Moran, et al.
BMJ Open|June 27, 2022
Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool applicationMuhammad Jami Husain, Mohammad Sabbir Haider, Renesa Tarannum, et al.
Journal of the American Heart Association|April 28, 2020
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and AffordabilityMuhammad Jami Husain, Biplab Kumar Datta, Deliana Kostova, et al.
Public Health in Practice (Oxford, England)|September 20, 2023
Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in EthiopiaSenait Alemayehu Beshah, Muhammad Jami Husain, Girma A Dessie, et al.
BMJ Open|March 1, 2014
Obesity in pregnancy: a retrospective prevalence-based study on health service utilisation and costs on the NHSKelly L Morgan, Muhammad A Rahman, Steven Macey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2025
Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care ClinicsLuis Michea, Thomas T Kim, Brian Hutchinson, et al.
Pageof 4

Showing results (21-30 of 40) with videos related to

Sort By:
Pageof 4
PLOS Global Public Health|February 12, 2024
Barriers to accessibility of medicines for hyperlipidemia in low- and middle-income countriesChaoyang Li, Garrison Spencer, Muhammad Jami Husain, et al.
MMWR. Morbidity and Mortality Weekly Report|May 29, 2015
Approaches for controlling illicit tobacco trade--nine countries and the European UnionHana Ross, Muhammad Jami Husain, Deliana Kostova, et al.
Seminars in Arthritis and Rheumatism|April 13, 2012
No increased rate of acute myocardial infarction or stroke among patients with ankylosing spondylitis-a retrospective cohort study using routine dataSinead Brophy, Roxanne Cooksey, Mark Atkinson, et al.
BMJ Open|April 16, 2024
Scaling hypertension treatment in 24 low-income and middle-income countries: economic evaluation of treatment decisions at three blood pressure cut-pointsBrian Hutchinson, Adam Walter, Norm Campbell, et al.
BMJ Global Health|September 11, 2020
The cost-effectiveness of hypertension management in low-income and middle-income countries: a reviewDeliana Kostova, Garrison Spencer, Andrew E Moran, et al.
BMJ Open|June 27, 2022
Cost of primary care approaches for hypertension management and risk-based cardiovascular disease prevention in Bangladesh: a HEARTS costing tool applicationMuhammad Jami Husain, Mohammad Sabbir Haider, Renesa Tarannum, et al.
Journal of the American Heart Association|April 28, 2020
Access to Cardiovascular Disease and Hypertension Medicines in Developing Countries: An Analysis of Essential Medicine Lists, Price, Availability, and AffordabilityMuhammad Jami Husain, Biplab Kumar Datta, Deliana Kostova, et al.
Public Health in Practice (Oxford, England)|September 20, 2023
Cost analysis of the WHO-HEARTS program for hypertension control and CVD prevention in primary health facilities in EthiopiaSenait Alemayehu Beshah, Muhammad Jami Husain, Girma A Dessie, et al.
BMJ Open|March 1, 2014
Obesity in pregnancy: a retrospective prevalence-based study on health service utilisation and costs on the NHSKelly L Morgan, Muhammad A Rahman, Steven Macey, et al.
Value in Health : the Journal of the International Society for Pharmacoeconomics and Outcomes Research|July 9, 2025
Economic Evaluation of the HEARTS Standardized Hypertension Treatment Program With Fixed-Dose Combination Pills in Chile Primary Care ClinicsLuis Michea, Thomas T Kim, Brian Hutchinson, et al.
Pageof 4